Loading viewer...
investor_presentation
Format: PDF investor_presentation
Revised investor presentation covering unaudited standalone and consolidated financial results for Q2 and H1 FY2024 ended September 30, 2023. The presentation provides financial performance updates and business insights for the financial services company.
conference
1 Pages
investor_presentation
24 Pages
Edenred
investor_presentation
Oncolytics